Synthesis of Silver Nano Particles Using Myricetin and the In-Vitro Assessment of Anti-Colorectal Cancer Activity: In-Silico Integration
The creation of novel anticancer treatments for a variety of human illnesses, including different malignancies and dangerous microbes, also potentially depends on nanoparticles including silver. Recently, it has been successful to biologically synthesize metal nanoparticles using plant extracts. The natural flavonoid 3,3′, 4′, 5,5′, and 7 hexahydroxyflavon (myricetin) has anticancer properties. There is not much known about the regulatory effects of myricetin on the possible cell fate-determination mechanisms (such as apoptosis/proliferation) in colorectal cancer. Because the majority of investigations related to the anticancer activity of myricetin have dominantly focused on the enhancement of tumor cell uncontrolled growth (i.e., apoptosis). Thus, we have decided to explore the potential myricetin interactors and the associated biological functions by using an in-silico approach. Then, we focused on the main goal of the work which involved the synthesis of silver nanoparticles and the labeling of myricetin with it. The synthesized silver nanoparticles were examined using UV-visible spectroscopy, dynamic light scattering spectroscopy, Fourier transform infrared spectroscopy, and scanning electron microscopy. In this study, we have investigated the effects of myricetin on colorectal cancer where numerous techniques were used to show myricetin’s effect on colon cancer cells. Transmission Electron Microscopy was employed to monitor morphological changes. Furthermore, we have combined the results of the colorectal cancer gene expression dataset with those of the myricetin interactors and pathways. Based on the results, we conclude that myricetin is able to efficiently kill human colorectal cancer cell lines. Since, it shares important biological roles and possible route components and this myricetin may be a promising herbal treatment for colorectal cancer as per an in-silico analysis of the TCGA dataset.
Топ-30
Журналы
|
1
2
|
|
|
Life
2 публикации, 7.41%
|
|
|
Nanomaterials
2 публикации, 7.41%
|
|
|
International Journal of Molecular Sciences
2 публикации, 7.41%
|
|
|
Frontiers in Genetics
1 публикация, 3.7%
|
|
|
Cells
1 публикация, 3.7%
|
|
|
Antibiotics
1 публикация, 3.7%
|
|
|
Phytotherapy Research
1 публикация, 3.7%
|
|
|
Cell Biochemistry and Function
1 публикация, 3.7%
|
|
|
Biomedicines
1 публикация, 3.7%
|
|
|
Analytica Chimica Acta
1 публикация, 3.7%
|
|
|
Materials Express
1 публикация, 3.7%
|
|
|
Journal of Agriculture and Food Research
1 публикация, 3.7%
|
|
|
Theriogenology
1 публикация, 3.7%
|
|
|
Scientific Reports
1 публикация, 3.7%
|
|
|
Geomicrobiology Journal
1 публикация, 3.7%
|
|
|
Combinatorial Chemistry and High Throughput Screening
1 публикация, 3.7%
|
|
|
Molecular Biology Reports
1 публикация, 3.7%
|
|
|
Journal of Cluster Science
1 публикация, 3.7%
|
|
|
Archives of Toxicology
1 публикация, 3.7%
|
|
|
Gold Bulletin
1 публикация, 3.7%
|
|
|
Chemico-Biological Interactions
1 публикация, 3.7%
|
|
|
Current Oncology
1 публикация, 3.7%
|
|
|
1
2
|
Издатели
|
2
4
6
8
10
|
|
|
MDPI
10 публикаций, 37.04%
|
|
|
Springer Nature
6 публикаций, 22.22%
|
|
|
Elsevier
5 публикаций, 18.52%
|
|
|
Wiley
2 публикации, 7.41%
|
|
|
Frontiers Media S.A.
1 публикация, 3.7%
|
|
|
American Scientific Publishers
1 публикация, 3.7%
|
|
|
Taylor & Francis
1 публикация, 3.7%
|
|
|
Bentham Science Publishers Ltd.
1 публикация, 3.7%
|
|
|
2
4
6
8
10
|
- Мы не учитываем публикации, у которых нет DOI.
- Статистика публикаций обновляется еженедельно.